Novartis AG Cash on Hand 2012-2026 | NVS

Novartis AG cash on hand for the quarter ending March 31, 2026 was $6.977B, a 3.04% decline year-over-year.

  • Novartis AG cash on hand for 2025 was $11.59B, a 13.87% decline from 2024.
  • Novartis AG cash on hand for 2024 was $13.457B, a 6.73% decline from 2023.
  • Novartis AG cash on hand for 2023 was $14.428B, a 23.78% decline from 2022.

Novartis AG Cash on Hand 2012-2026 | NVS

  • Novartis AG cash on hand for 2025 was $11.59B, a 13.87% decline from 2024.
  • Novartis AG cash on hand for 2024 was $13.457B, a 6.73% decline from 2023.
  • Novartis AG cash on hand for 2023 was $14.428B, a 23.78% decline from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B